Login Register
icon_bulk_orderBulk order Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > DLL4

DLL4

Brief Information

Name:Delta-like protein 4
Target Synonym:Delta-Like Protein 4,Notch Ligand Delta-2,DLL4,Delta4,Delta-Like 4 (Drosophila),Delta-Like 4 Homolog (Drosophila),AOS6,Hdelta2,Notch Ligand DLL4,Delta Like Canonical Notch Ligand 4,Delta 4,Delta Ligand 4,Delta-Like 4 Protein,Drosophila Delta Homolog 4,Delta-Like 4 Homolog
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
DL4-H525a Human Human DLL4 Protein, Fc Tag, Ultra-low endotoxin (MALS verified)
DL4-H525a-structure
DL4-H525a-sds
DL4-H525a-elisa_1
DL4-H5227 Human Human DLL4 Protein, His Tag (MALS verified)
DL4-H5227-structure
DL4-H5227-sds
DL4-H5227-elisa_1
DL4-H5259 Human Human DLL4 Protein, Fc Tag
DL4-H5259-structure
DL4-H5259-sds
DL4-H5259-elisa_1

Part of Bioactivity data

DL4-H5227-ELISA
Human DLL4, His TagHuman DLL4, His Tag (Cat. No. DL4-H5227) ELISA bioactivity

Immobilized Human DLL4, His Tag (Cat. No. DL4-H5227) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human DLL4 Antibody, Human IgG1 with a linear range of 0.1-4 ng/mL (QC tested).

DL4-H525a-MALS-HPLC
Human DLL4, Fc Tag (Cat. No. ) MALS images

The purity of Human DLL4, Fc Tag (Cat. No. DL4-H525a) is more than 90% and the molecular weight of this protein is around 160-195 kDa verified by SEC-MALS.

Bioactivity-ELISA
Human DLL4, Fc TagHuman DLL4, Fc Tag (Cat. No. DL4-H525a) ELISA bioactivity

Immobilized Human DLL4, Fc Tag (Cat. No. DL4-H525a) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human DLL4 Antibody, Human IgG1 with a linear range of 2-16 ng/mL (QC tested).

Synonym Name

DLL4,Delta4

Background

Delta-like protein 4 (DLL4) is also known as Drosophila Delta homolog 4 (Delta4), which contains one DSL domain and eight EGF-like domains. DLL4 is expressed in vascular endothelium. DLL4 is involved in the Notch signaling pathway as Notch ligand, which can activates NOTCH1 and NOTCH4. DLL4 is involved in angiogenesis and negatively regulates endothelial cell proliferation and migration and angiogenic sprouting. DLL4 can bind to Notch-1 and Notch-4.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Navicixizumab OMP-305B83 Phase 3 Clinical Oncomed Pharmaceuticals Ovarian Neoplasms; Solid tumours; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms Details
Dilpacimab ABT-165; DVD-Ig ABT-165 Phase 2 Clinical Abbvie Inc Solid tumours; Neoplasms; Colorectal Neoplasms Details
TR-009 NOV-1501; ABL001-ABL Bio; ABL-001-ABL Bio; ES-104; CTX-009 Phase 2 Clinical Abl Bio Solid tumours; Neoplasms; Colorectal Neoplasms; Bile Duct Neoplasms Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message